Share
TRUEinvivo is pleased to announce that it went live on the SyndicateRoom investment platform on 27th February 2019. This enables the company to be visible to the wide network of potential investors who are registered with SyndicateRoom. The company chose SyndicateRoom as its online investment partner because of its excellent reputation in the equity crowdfunding market, its high levels of vetting and due diligence, and the professional help it gives its clients to present themselves well. SyndicateRoom joins TRUEinvivo’s offline investment network partner Nexus Investment Ventures Ltd (NIVL) in connecting TRUEinvivo with High Net Worth or Sophisticated potential investors. Note that this is an information news post and is not an invitation to invest in the company.
Related Posts
Revolutionary DOSEmapper™ reader produces glow curve graph, offering rapid measurement compared to traditional TLD readers.
Mount Vernon Cancer Centre pioneers first internal invivo dosimetry with TRUEnvivo® DOSEmapper™, revolutionising radiotherapy precision, patient safety, and treatment accuracy.
This order is for a number of DOSEmapper™ devices and for our DOSEmapper™ Bead Reading Service.
TrueInvivo's implant improves cancer treatment accuracy, accessible globally, supported by UKTI Sirius Programme.
